Boundless Bio, Inc.
NASDAQ:BOLDBiotechnology
+$1.20 today
- Market cap
- $56.67M
- Beta
- 0.97
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$2.50
Volume 0.15M
Average 0.22M
BOLD Total Non-current Assets
All assets not expected to be converted to cash within one year.
Boundless Bio, Inc.NASDAQ: BOLD
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets falls 8.9% from a year ago
Total non-current assets stood at $46.35M at the end of Q1 FY2026, down 8.9% from a year earlier and down 2.3% from the prior quarter. Over 3 fiscal years it compounded at +75.4% a year.
Context
- Total non-current assets amounted to 32.9% of total assets at the end of Q1 FY2026, up 6.3 pp from a year earlier.
- Total non-current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total non-current assets keeps falling in the next quarterly balance sheet after a -8.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 47.45M USD
- Year-over-year change
- -8.8%
- 4-year CAGR
- +4.9%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.45M | -8.8% |
| FY2024 | 2024-12-31 | 52.02M | +814.2% |
| FY2023 | 2023-12-31 | 5.69M | -35.3% |
| FY2022 | 2022-12-31 | 8.79M | -77.5% |
| FY2021 | 2021-12-31 | 39.15M | — |
Total Non-current Assets vs competitors
How BOLD compares with its peers on the latest reported figures
- BOLD's Mar 2026 total non-current assets of $46.35M is the highest of the 4 companies compared; the peer median is $982K.
- Its year-over-year change of -8.9% is the 2nd highest of 4, against a peer median of -38.0%.
- Total non-current assets amounts to 32.9% of total assets for BOLD, versus a peer median of 1.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $46.35M | -8.9% | +75.4% | 32.9% | |
| Mar 2026 | $6.47M | -38.0% | -23.3% | 10.2% | |
| Mar 2026 | $982K | +63.1% | +2.4% | 1.8% | |
| Mar 2026 | $0 | -100.0% | -20.0% | 0.0% | |
| Peer median (excluding BOLD) | $982K | -38.0% | -20.0% | 1.8% | |
Competitors are the stored peer set for BOLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 34.29M | 10.95M | 23.71M | 26.59M | 17.87M |
| Short-term Investments | 38.74M | 55.77M | 97.05M | 125.53M | 89.71M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.54M | 1.32M | 3.45M | 2.28M | 2.03M |
| Total Current Assets | 74.57M | 68.04M | 124.2M | 154.39M | 109.61M |
| Property, Plant & Equipment (Net) | 3.1M | 7.73M | 4.58M | 51.36M | 46.88M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 34.99M | 0 | 560K | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.07M | 1.07M | 555K | 659K | 573K |
| Total Non-current Assets | 39.15M | 8.79M | 5.69M | 52.02M | 47.45M |
| Total Assets | 113.72M | 76.83M | 129.89M | 206.41M | 157.06M |
| Account Payables | 1.08M | 1.4M | 2.22M | 1.27M | 1.49M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.51M | 2.55M | 2.9M | 2.78M | 2.64M |
| Total Current Liabilities | 3.87M | 7.73M | 9.36M | 8.14M | 12.54M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 148.04M | 147.95M | 247.62M | 0 | 0 |
| Total Non-current Liabilities | 148.04M | 150.8M | 247.62M | 47.63M | 45.87M |
| Total Liabilities | 151.91M | 158.53M | 256.98M | 55.77M | 58.41M |
| Common Stock | 2K | 2K | 0 | 2K | 2K |
| Retained Earnings | (40.77M) | (86.68M) | (136.11M) | (201.47M) | (259.67M) |
| Accumulated OCI | (175K) | (398K) | 40K | 121K | 64K |
| Other Stockholders Equity | 0 | 0 | 2K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (38.19M) | (81.7M) | (127.08M) | 150.64M | 98.65M |
| Total Debt | 377K | 5.18M | 2.2M | 47.63M | 49.04M |
| Net Debt | (33.91M) | (5.77M) | (21.51M) | 21.05M | 31.17M |
Boundless Bio, Inc.
NASDAQ:BOLD
Intrinsic Alpha fair value
Locked
Current Price
$2.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.